OA 05.07 Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC

Autor:	S.-B. Kim, Byoung Chul Cho, D. Kim, Rafal Dziadziuszko, Radka Obermannova, Anna Cecilia Bettini, Pieter E. Postmus, Zhe Chen, Scott A. Laurie, K. Park, Alessandra Bearz, Vanessa Q. Passos, Gloria Borra, Sarayut Lucien Geater, Karen Osborne, Sergey Orlov
Rok vydání:	2017
Předmět:	0301 basic medicine Pulmonary and Respiratory Medicine Meal Ceritinib business.industry Pharmacology 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Medicine business medicine.drug
Zdroj:	Journal of Thoracic Oncology. 12:S1757
ISSN:	1556-0864
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c5c0ef3c0be06ebf6311e66a36230bf6 https://doi.org/10.1016/j.jtho.2017.09.352 Zobrazit plný text záznamu